Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Media Articles Related to Meprobamate
The right programs can help college students suffering from depression, anxiety and stress
Source: Anxiety / Stress News From Medical News Today [2015.04.23]
Is it possible to prevent mental health problems in higher education students?
Antidepressant use in pregnancy associated with anxiety symptoms in 3-year-olds
Source: Depression News From Medical News Today [2015.04.23]
Three-year-old siblings exposed to antidepressants in pregnancy show increased anxiety symptoms compared to their unexposed siblings.
Scientists find brain circuitry that raises anxiety during nicotine withdrawal
Source: Anxiety / Stress News From Medical News Today [2015.04.22]
Increased anxiety is common during nicotine withdrawal. After discovering the brain circuitry responsible, scientists suggest ways people trying to quit may avoid the side effect.
Health Tip: Dealing With Bedtime Anxiety
Source: MedicineNet Sleep Specialty [2015.04.22]
Title: Health Tip: Dealing With Bedtime Anxiety
Category: Health News
Created: 4/22/2015 12:00:00 AM
Last Editorial Review: 4/22/2015 12:00:00 AM
Studies link air pollution as risk factor for anxiety and trigger for stroke
Source: Water - Air Quality / Agriculture News From Medical News Today [2015.03.25]
Two new studies published in The BMJ examine associations between fine particulate air pollution and levels of anxiety and incidence of stroke.
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
Reports of Suspected Meprobamate Side Effects
Toxicity TO Various Agents (28),
Respiratory Arrest (15),
Cardiac Arrest (15),
Accidental Death (14),
Drug Abuse (11),
Completed Suicide (11),
Multiple Drug Overdose Accidental (5),
Pulmonary Congestion (5),
Pulmonary Oedema (4), more >>
Page last updated: 2015-04-23